In-Joon Baek

In-Joon Baek

Auto-generated profile, based on publicly available information

In-Joon Baek

Center for Genomic Integrity, Institute for Basic Science, Ulsan 44919, Republic of Korea

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
TKTaejoon Kwon
Taejoon Kwon
JRJae Sun Ra
Jae Sun Ra
SLSoyoung Lee
Soyoung Lee
IBIn-Joon Baek
In-Joon Baek
KKKeon Woo Khim
Keon Woo Khim
KMKyungjae Myung
Kyungjae Myung
Significance: The targeted killing of cancer cells without affecting surrounding normal cells is the most desirable approach for cancer therapy; however, it cannot be easily achieved, owing to the shared properties of normal and cancer cells. Using CRISPR-Cas9 targeting multiple cancer-specific mutations, we developed an innovative approach called cancer-specific insertions and deletions attacker that can induce targeted cancer cell death by simultaneous and multiple DNA double-strand breaks. As demonstrated in cell lines, cancer patient–driven cells and xenografts, the concept proposed in this study may become a potential approach for personalized cancer treatments.